BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLABORATIVE
Data sourced from IRS 990 public filings
BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLABORATIVE We are a unique international collaborative of blood providers industry and academic experts that work together to undertake studies publish guidance and recommend procedures aiming to improve the safety quality and effectiveness of transfusion medicine and cellular therapies worldwide. We use our pooled resources to take on projects and challenges that would be unfeasible to address otherwise. We create international impact in transfusion and cellular therapies for the benefit of donors and patients.
Annual Revenue
$223,730
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $354,603 | $449,010 | $751,328 |
| 2023 | $330,139 | $395,256 | $837,145 |
| 2022 | $378,796 | $299,996 | $902,262 |
| 2021 | $367,660 | $162,485 | $823,462 |
| 2020 | $223,730 | $162,411 | $618,287 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
Rebecca Cardigan PhD
President
Zbigniew Szczepiorkowski MD PhD
Treasurer Interim President
Michael F Murphy MD
Consulting Past President
David Stroncek MD
Director
David McKenna MD
Director
Ralph Vassallo MD
Director
Marc Germain MD
Director
Denese Marks PhD
Director
Jason Acker PhD MBA
Director
Meghan Delaney DO MPH
Director
Showing 10 of 12 key personnel.
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.